chrisvoncsefalvay/vaers-outcomes huggingface dataset:
The patient reports extreme redness and tingling from the elbow up to her shoulder after receiving the vaccination. The erythema is accompanied by mild pain upon being touched but no joint pain was reported. The patient also reported fatigue, however association with the vaccine administration was unclear.
Bradycardia, asystole, resp arrest; dx vasovagal episode w/ a systole;
Oddest thing, I know how bizarre this sounds.  About 8 hours after my injection, I had moderate pain in my left (injection) arm.  However, I also developed the same or greater level of pain in my right (non-injection) arm.  The pain was located in my upper arm, exactly the same area where I experienced pain in my injection arm.  The pain lasted about 18 hours, fading away after that.   I had the same reaction to the second dose of the vaccine, given three weeks following the first.  I had less pain after the second shot, and the "mirror" pain in the other arm was also less.  This lasted between 12 and 18 hours, and then the pain in both arms faded away.
cold in nose and throat; soreness at injection site; This spontaneous case was reported by a consumer and describes the occurrence of NASOPHARYNGITIS (cold in nose and throat) and PAIN (soreness at injection site) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 12-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced NASOPHARYNGITIS (cold in nose and throat) and PAIN (soreness at injection site). At the time of the report, NASOPHARYNGITIS (cold in nose and throat) and PAIN (soreness at injection site) outcome was unknown. Not Provided    The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   Concomitant product use was not provided by the reporter.  No treatment specified.
She passed out for 60 seconds and had a seizure for about 30 seconds.  When she woke up, she was disoriented and started to vomit for about 5 minutes.  I recommended to go to the ER, but she said she will be fine and was escorted out by the family member to go home.
Vaccine administered after more than 1 temperature excursion; Vaccine administered after more than 1 temperature excursion; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after more than 1 temperature excursion) and POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered after more than 1 temperature excursion) in a 40-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Jan-2021 at 1:58 PM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 12-Jan-2021 at 1:58 PM, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered after more than 1 temperature excursion). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after more than 1 temperature excursion). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after more than 1 temperature excursion) and POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered after more than 1 temperature excursion) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The age of patient was provided as 40.95.  Concomitant products were not provided.  On 12-Jan-2021, Excursion time was 08 AM, temperature was 34 and at 9 AM temperature was 34, total doses given for the day was 30, condition of vaccine prior to administration was not frozen, vaccine was moved to fridge on 8-Jan-2021, vial was moved to clinic on 12-Jan-2021. 3 vials were sent to clinic. Vaccine BUD date was 7-Feb-2021.  The vials were only punctured right before administration and all doses were drawn from the vial due to high-pace clinic.  Temperature recordings were taken using a Fisher brand traceable temperature monitor at every hour.  After administration, the vial was returned to the freezer/refrigerator, or maintained at room temperature.  It was reported that the patient was administered with vaccines that experienced more than 1 temperature excursion during 33 weeks in 2021. The HCP explained that each time a vial was put into a cooler, there was a period of 1 hour or 1 and half hour approximately, when the temperature data logger registered 34 or 35 degree F.  Treatment medications were not reported.
Information has been received from a physician concerning a 16 year old female patient who on an unspecified date was vaccinated IM with the second dose of Gardasil vaccine (Lot Number not reported). Reporter indicated that the patient had fainted and was fine before leaving the office. No medical attention was sought. Patient outcome was recovered. No product quality complaint was involved. Additional information has been requested.
swelling and bruising at the wrist area of the shot arm  (was wearing a watch, during injection and during the night)
Morning after receiving vaccine (01/14/2021), woke up and was having chills, weakness, "head felt like it did when having covid, dizziness, light-headed". Urinary incontinence and memory loss, and hallucinations on 01/14/2021. Blue color to left deltoid started 01/13/2021 in PM and on 01/14/2021 when waking up, left upper arm was blue and redness noted down to elbow. "I have laid on the couch and that's basically all I've done since getting the shot."
Suspected Vaccination failure; shingles on my forehead / shingles over my eye visits to eye Dr, to make sure it did not get into eye/ Shingles shot gave me shingles; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   The reporter considered the vaccination failure and shingles to be related to Shingles vaccine.  Additional details were provided as follows: This case was reported by the patient himself/ herself. The age at vaccination was not reported. The patient got the shingle shot and then a little small amount of the shingles on the forehead over the eye.  The patient visited the eye doctor to make sure it did not get into eye. The patient stated that shingles shot gave him/ her shingles, and to not listen to this add. This case was considered as suspected vaccination failure since the details regarding completion of primary immunization schedule, time to onset and laboratory test confirming shingles were unknown at the time of reporting.
Initial misuse report received from healthcare professional on 30 October 2014. The cases were received on 21 March 2014 at GPV. A 65-year-old male patient received a dose of FLUZONE instead of FLUZONE HD. (No other information was provided regarding the patient). No adverse event was reported. List of documents held  by sender: none
Fever and chills started 6 hours after vaccination dose.  Fever measured 102 degrees the night of the vaccination, 100.1 the next day.  Headache and nausea accompanied fever for 36 hours.  I called Occupational Health at noon the next day to see if I could take Ibuprophen to reduce the fever and they said I could.  Fever was reduced after dose, but came back 5 hours later until next dose of Ibuprophen was taken.  This lasted for 36 hours until fever finally went away.  I then developed a bad sinus infection that lasted for 5 days following the fever.
Extreme knee pain and finger pain, overall body aches and pain since the 2nd vaccine.
Sudden sensorineural hearing loss in the right ear. Initially hearing loss was profound and has recovered partially to a moderate hearing loss. Hearing has not recovered to baseline as of 2/10/21. Pt also had tinnitus in the right ear which has improved but still bothersome.  Patient was started on prednisone on 2/10 at date of initial consultation. Will return for follow-up audiogram in 2 weeks.
5/25/21 beginning with rash of red raised dots, sensitive, occurring on both forearms, anterior and posterior torso, and medial thighs, somewhat itchy. 5/30/21 rash has transitioned to large red patches, some starting to peel, very itchy and somewhat burning. 6/6/21 rash still peeling, calmed down on most parts of anterior torso, back still peeling, mild itchy and burning persistent, left forearm mostly clear, right forearm wrist and palm splotches migrating around red and peeling. Splotches migrating around right anterior torso and side where rubbing on clothes and carrying child more on dominant side.
Kinrix was administrated instead of Boostrix to a 14 years old; Kinrix was administrated instead of Boostrix; This case was reported by a other health professional via call center representative and described the occurrence of inappropriate age at vaccine administration in a 14-year-old female patient who received DTPa-IPV (Kinrix) (batch number hb7l7, expiry date 31st August 2021) for prophylaxis.   Co-suspect products included dtpa-ipv vaccine pre-filled syringe device (Kinrix Pre-Filled Syringe Device) injection syringe for prophylaxis.   On 18th June 2021, the patient received Kinrix and Kinrix Pre-Filled Syringe Device. On 18th June 2021, unknown after receiving Kinrix and Kinrix Pre-Filled Syringe Device, the patient experienced inappropriate age at vaccine administration and wrong vaccine administered. The action taken with Kinrix Pre-Filled Syringe Device was unknown. On an unknown date, the outcome of the inappropriate age at vaccine administration and wrong vaccine administered were unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.  Additional details were provided as follows: The medical assistance reported that, Kinrix was administrated instead of Boostrix to a 14 years old patient, which led to inappropriate age at vaccine administration and wrong vaccine administered. No adverse event was reported. The reporter consented to follow up.
This case was reported by a healthcare professional via a sales representative and described the occurrence of low grade fever in a 30-year-old female subject who was vaccinated with BOOSTRIX (GlaxoSmithKline). In February 2012 the subject received a dose of BOOSTRIX at 0.5 ml in an unknown deltoid. Less than one month after vaccination with BOOSTRIX, the subject experienced low grade fever and body pain. At the time of reporting the outcome of the events was unspecified. The healthcare professional considered the events were possibly related to vaccination with BOOSTRIX.
PATIENT STATED THAT 18 DAYS AFTER HIS FIRST DOSE HE IS STILL EXPERIENCING THE FOLLOWING SYMPTOMS : SORE LEGS/ LEG CRAMPS, FATIQUE, HEADACHE, GENERAL MALAISE, PATIENT STATED HE HAS "HIT BY THE TRUCK FEELING". HE HAD FEVER OVER 103 FOR THE FIRST 3 DAYS ONLY. I ADVISED  PATIENT TO FOLLOW UP WITH HIS PCP. IN THE MEANTIME, I RECOMMENDED HYDRATION, IBUPROFEN OR TYLENOL.
Later in day intense headache and now two days later still intense headache, muscle aches/soreness(mostly arms neck back), very tired, chills, low grade temp. flu like).  Even had to miss work.
55 year old male with hx remote pneumonia, no other medical hx presents for evauation of cough, chest tightness with inspiration and shortness of breath. He was diagnosed COVID 19 positive on 1/18 21 after complaing of a severe sore throat and fatigue and fever and chills. He was ok up until today where he develped chest tightness, pleuritic in nature with shortness of breath, no fever or chills, no hypoxia, 99% on room air, chest xray done which was essentially clear but CTA done showed bilat pneumonia but NO PE. He is vaccinated with Moderna x 2, last on Feb 2021
Have had diarrhea everyday since the day after the vaccine,12Aug2021; Lost weight; The initial safety information received was reporting only non-serious adverse drug reaction(s), Upon receipt of follow-up information on 28Sep2021, this case now contains serious adverse reaction(s). Information processed together.   This is a spontaneous report from a contactable consumer.  A 64-years-old female patient received bnt162b2 (BNT162B2), dose 1 intramuscular, administered in Arm Left on 11Aug2021 12:30 (Batch/Lot Number: FC3181) as DOSE 1, SINGLE for covid-19 immunisation.  Medical history included tobacco user.The patient previously took penicillin n and experienced anaphylaxis.  The patient had diarrhea everyday since the day after the vaccine on 12Aug2021, lost weight on Aug2021.  The patient underwent lab tests and procedures which included blood pressure measurement: 119/74   on 16Sep2021 Arm(L) , body mass index: 27.4   on 16Sep2021, body temperature: 98.2 fahrenheit on 16Sep2021, heart rate: 98   on 16Sep2021 98 BPM , oxygen saturation: 98 % on 16Sep2021, sars-cov-2 test: negative   on 27Aug2021, weight: 170 lbs on 16Sep2021. The patient presents with a chief complaint of diarrhea of the abdomen since approximately Mon, 16Aug2021. It has the following qualities: watery and loose stool. Context - Initial History: The patient reports that it had a sudden onset. The patient had no similar problems in the past. The patient reports no contact with a person with similar symptoms. The patient reports that the onset was: not associated with recent travel; not associated with camping, not associated with eating foods; not associated with drinking dirty water, not associated with heavy/fatty meals; not associated with exertion; not associated with taking antibiotics; Patient reports not testing positive for COVID-19 AND being asymptomatic for more than 24 days. Patient reports not receiving a COVID-19 vaccine.On 12Aug2021 Developed Diarrhea that has Lasted more Than A month. At first for About 3 weeks was Acute, Lost weight Imodium did not work. Benedryl helped slow it Down Went To doctor no one knows what to do. she gave me Azithromycin did not work. Continuing with Diarrhea, Better but not gone Almost six weeks After VAX.  Therapeutic measures were taken as a result of have had diarrhea everyday since the day after the vaccine,12Aug2021.Outcome of Diarrhea was recovering, of weight decreased was unknown.  No follow-up attempts are possible. No further information is expected
Immediately after receiving the vaccine, the patient had trouble breathing and chest tightness. We administered an EpiPen and the patient began to feel better within minutes. EMS was called and took the patient to the hospital in stable condition
Two hours after receiving the shot ,blood sugar levels were higher than the normal; This spontaneous case was reported by a consumer and describes the occurrence of BLOOD GLUCOSE INCREASED (Two hours after receiving the shot ,blood sugar levels were higher than the normal) in a 69-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006M20A) for COVID-19 vaccination.     Concurrent medical conditions included Diabetes. Concomitant products included TRAMADOL for Pain.    On 19-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Feb-2021, the patient experienced BLOOD GLUCOSE INCREASED (Two hours after receiving the shot ,blood sugar levels were higher than the normal). At the time of the report, BLOOD GLUCOSE INCREASED (Two hours after receiving the shot ,blood sugar levels were higher than the normal) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 19-Feb-2021, Blood glucose increased: 156 mg/dl (High) Patient usually has blood sugar in the range 99-120 mg/dl.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications also include 2 different injections for diabetes a day.  Treatment information was not provided.
Pfizer-BioNTech CoVID-19 Vaccine .   Routine Office visit 3/11/21 with surgeon, previous melanoma as follow up.  She advised my lymph nodes were swollen on the right side in my groin and under my arm.  I also received my COVID vaccine in my right arm.   Doctor will do another follow up in 30 days on 4/15/21.
Pt was inject with anthrax in left forarm (ID). Anthrax Vaccine Immunization Program was called for further instructions. They explained what pt should look for as far as sign/symptom. They also stated that since pt was on #3 of series, that the anthrax given would count in the series and progress with schedule. Pt felt fine and was told to follow up if any signs/symptoms occurred.
At 5:05 am on April 11, approx. 37 hours after I received the shot, I awakened to a rapid muscle convulsion in my left shoulder muscle, at the approximate location of the injection. I counted between 2 to 6 contractions per second (yes, it was a very quick twitch that involved my whole upper arm). It went on for at least 10 minutes, then paused for less than a minute and then resumed. This was a pronounced muscle spasm which I cannot remember having before. I have had twitching eyelids or facial muscle that would twitch for a few minutes in the past, but this went on for over 30 minutes, and I am not sure it is done. Also, this was much more intense than the above-referenced twitches. The location and time relative to my shot makes me fairly certain that this is an effect of the vaccine. I have not exercised or done anything to cause this to my knowledge. Of course, this seems like a harmless side effect, but my concern is that my heart muscle reacting to this in a similar fashion could be more serious.
This spontaneous report was received from a physician via company representative and refers to a female patient of unknown age. The patient's pertinent medical history, drug reactions and allergies were not reported. Concomitant therapies were not provided. On an unknown date in 2006, the patient was vaccinated with a dose of PNEUMOVAX 23 for prophylaxis (route of administration, anatomical location and expiration date were not reported). On an unknown date in 2006, the patient experienced a local site reaction. On an unspecified date, the patient had her spleen removed for unspecified reason. The patient sought medical attention (details were not provided). The outcome of the events was unknown. Causality assessment was not provided. Upon internal review, the event of spleen removal was determined to be medically significant.
Hospitalized (10.14 - 10.19.21);  COVID-19 positive (10.14.21);  fully vaccinated (3.3.21) Admission Date: 10/14/2021 Discharge Date: 10/19/2021 COVID-19 Assessment & Plan Patient's home caregiver was positive for COVID-19.  Patient has been vaccinated as positive for COVID.  He is room air Will discontinue remdesivir and Decadron Continue isolation during hospitalization Patient is felt to be stable from a respiratory standpoint and will discontinue further laboratory monitoring related to COVID DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Hypoxia COVID-19 Pneumonia due to COVID-19 virus  HOSPITAL COURSE: The patient is an 87-year-old gentleman recently discharged from our facility for suspected urinary tract infection who returns with complaints of ongoing weakness and cough.  On admission the patient was discovered to be suffering from COVID pneumonia.  During the patient's previous admission discussions were had on sending the patient to subacute rehab based on his weakness.  At that time the patient was not amendable to subacute rehab and was subsequently discharged home.  Family reports they have had a difficult time caring for him as they have become ill with COVID as well.  The patient was initially started on Decadron, however he was quickly weaned to room air if felt to be stable from a respiratory  standpoint.  While hospitalized the patient has adamantly refused subacute rehab and will not go to facilities.  Additionally, family has stated they are unable to care for the patient at home due to them recovering from COVID.  Over the last couple days there has been talk about discharging home with home care along with discussions of hospice care.  The patient and family have agreed to move the patient into hospice care.  The patient will be discharged today to be admitted with Hospice.
Extreme muscle aches and pain. T-99.7, P.70, B/P 118/62.
swollen middle finger; inflammed middle finger; This spontaneous case was reported by a physician and describes the occurrence of PERIPHERAL SWELLING (swollen middle finger) and INFLAMMATION (inflammed middle finger) in a 32-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 044A21A and 036B21A) for COVID-19 vaccination.     Concomitant products included BUPROPION HYDROCHLORIDE (WELLBUTRIN) and HYDROCHLOROTHIAZIDE, LISINOPRIL (LISINOPRIL HCTZ) for an unknown indication.   On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 15-Apr-2021, the patient experienced PERIPHERAL SWELLING (swollen middle finger) and INFLAMMATION (inflammed middle finger). The patient was treated with IBUPROFEN at an unspecified dose and frequency; SULFAMETHOXAZOLE, TRIMETHOPRIM (BACTRIM) at an unspecified dose and frequency and CEFALEXIN (KEFLEX [CEFALEXIN]) at a dose of for 10 days. At the time of the report, PERIPHERAL SWELLING (swollen middle finger) and INFLAMMATION (inflammed middle finger) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Treatment medication includes Hot-cold Compress,; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
The evening of the vaccination, Pt reported tingling down both arms, weakness in knees and lower back, calves.  This weakness worsens when going down the steps.  Pt also reported a headache for two days following vaccine.  Currently (12 days post vaccination) pt describes arm soreness (both arms) as in "lifting lots of weights," generalized weakeness/fatigue and continued soreness in knees.